Quantbot Technologies LP Invests $685,000 in Azenta, Inc. (NASDAQ:AZTA)

Quantbot Technologies LP acquired a new stake in Azenta, Inc. (NASDAQ:AZTA) during the 4th quarter, HoldingsChannel.com reports. The fund acquired 13,705 shares of the company’s stock, valued at approximately $685,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Maryland State Retirement & Pension System acquired a new stake in Azenta in the 4th quarter valued at about $924,000. Thrivent Financial for Lutherans increased its stake in shares of Azenta by 206.5% during the fourth quarter. Thrivent Financial for Lutherans now owns 35,223 shares of the company’s stock worth $1,761,000 after buying an additional 23,731 shares during the period. Corient Private Wealth LLC increased its stake in shares of Azenta by 12.7% during the fourth quarter. Corient Private Wealth LLC now owns 28,505 shares of the company’s stock worth $1,425,000 after buying an additional 3,221 shares during the period. Royce & Associates LP raised its holdings in Azenta by 2.4% in the fourth quarter. Royce & Associates LP now owns 758,068 shares of the company’s stock valued at $37,903,000 after acquiring an additional 18,091 shares in the last quarter. Finally, Catalyst Funds Management Pty Ltd grew its holdings in Azenta by 123.0% during the 4th quarter. Catalyst Funds Management Pty Ltd now owns 4,684 shares of the company’s stock worth $234,000 after acquiring an additional 2,584 shares in the last quarter. 99.08% of the stock is currently owned by hedge funds and other institutional investors.

Azenta Price Performance

Shares of AZTA opened at $35.52 on Friday. Azenta, Inc. has a 1-year low of $35.06 and a 1-year high of $63.58. The stock has a market cap of $1.62 billion, a PE ratio of -11.92 and a beta of 1.52. The firm has a fifty day moving average price of $45.47 and a 200 day moving average price of $46.35.

Azenta (NASDAQ:AZTA) last posted its earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. As a group, equities analysts expect that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Wall Street Analyst Weigh In

AZTA has been the topic of a number of analyst reports. Needham & Company LLC raised their price objective on shares of Azenta from $55.00 to $59.00 and gave the company a “buy” rating in a report on Thursday, February 6th. Evercore ISI raised their price target on Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a research note on Thursday, February 6th. Stephens reaffirmed an “overweight” rating and set a $60.00 price objective on shares of Azenta in a research report on Thursday, January 2nd. Finally, TD Cowen raised Azenta to a “hold” rating in a research report on Thursday, February 27th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $58.75.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.